159 related articles for article (PubMed ID: 15219383)
1. Association of tumor necrosis factor and human leukocyte antigen DRB1 alleles with Graves' ophthalmopathy.
Bednarczuk T; Hiromatsu Y; Seki N; Płoski R; Fukutani T; Kuryłowicz A; Jazdzewski K; Chojnowski K; Itoh K; Nauman J
Hum Immunol; 2004 Jun; 65(6):632-9. PubMed ID: 15219383
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test.
Tsuchiya N; Kawasaki A; Tsao BP; Komata T; Grossman JM; Tokunaga K
Genes Immun; 2001 Oct; 2(6):317-22. PubMed ID: 11607787
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism of the 5' flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese.
Kamizono S; Hiromatsu Y; Seki N; Bednarczuk T; Matsumoto H; Kimura A; Itoh K
Clin Endocrinol (Oxf); 2000 Jun; 52(6):759-64. PubMed ID: 10848881
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis.
Wijnen PA; Nelemans PJ; Verschakelen JA; Bekers O; Voorter CE; Drent M
Tissue Antigens; 2010 Mar; 75(3):262-8. PubMed ID: 20070603
[TBL] [Abstract][Full Text] [Related]
5. Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB1*0304-DQB1*02-DQA1*0501.
Heward JM; Allahabadia A; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
Clin Endocrinol (Oxf); 1999 Jul; 51(1):115-8. PubMed ID: 10468973
[TBL] [Abstract][Full Text] [Related]
6. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.
Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R
Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242
[TBL] [Abstract][Full Text] [Related]
7. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
Heward JM; Allahabadia A; Daykin J; Carr-Smith J; Daly A; Armitage M; Dodson PM; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
J Clin Endocrinol Metab; 1998 Oct; 83(10):3394-7. PubMed ID: 9768636
[TBL] [Abstract][Full Text] [Related]
8. Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese.
Hamaguchi K; Kimura A; Seki N; Higuchi T; Yasunaga S; Takahashi M; Sasazuki T; Kusuda Y; Okeda T; Itoh K; Sakata T
Tissue Antigens; 2000 Jan; 55(1):10-6. PubMed ID: 10703602
[TBL] [Abstract][Full Text] [Related]
9. TNF-alpha promoter polymorphisms and extended HLA and TNF-alpha haplotypes in Koreans based on 100 families.
Park YJ; Park H; Park MH
Tissue Antigens; 2004 Jan; 63(1):75-9. PubMed ID: 14651527
[TBL] [Abstract][Full Text] [Related]
10. HLA-DRB1*03 is a susceptibility gene in patients with Graves' disease with and without ophthalmopathy.
Yarman S; Oguz F; Carin M
Int J Immunogenet; 2007 Feb; 34(1):23-5. PubMed ID: 17284224
[TBL] [Abstract][Full Text] [Related]
11. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease.
Hunt PJ; Marshall SE; Weetman AP; Bunce M; Bell JI; Wass JA; Welsh KI
Clin Endocrinol (Oxf); 2001 Oct; 55(4):491-9. PubMed ID: 11678832
[TBL] [Abstract][Full Text] [Related]
12. Significance of HLA in the development of Graves' orbitopathy.
Stasiak M; Zawadzka-Starczewska K; Tymoniuk B; Stasiak B; Lewiński A
Genes Immun; 2023 Feb; 24(1):32-38. PubMed ID: 36639701
[TBL] [Abstract][Full Text] [Related]
13. Significance of HLA in Graves' disease and Graves' orbitopathy in Asian and Caucasian populations - a systematic review.
Stasiak M; Stasiak B; Zawadzka-Starczewska K; Lewiński A
Front Immunol; 2023; 14():1256922. PubMed ID: 37841270
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA-DRB1 alleles associated with Graves' disease in Koreans by sequence-based typing.
Jang HW; Shin HW; Cho HJ; Kim HK; Lee JI; Kim SW; Kim JW; Chung JH
Immunol Invest; 2011; 40(2):172-82. PubMed ID: 21062236
[TBL] [Abstract][Full Text] [Related]
15. Human leucocyte antigen alleles confer susceptibility and progression to Graves' ophthalmopathy in a Southern Chinese population.
Huang X; Liu G; Mei S; Cai J; Rao J; Tang M; Zhu T; Chen W; Peng S; Wang Y; Ye Y; Zhang T; Deng Z; Zhao J
Br J Ophthalmol; 2021 Oct; 105(10):1462-1468. PubMed ID: 33221730
[TBL] [Abstract][Full Text] [Related]
16. Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.
Jurecka-Lubieniecka B; Ploski R; Kula D; Krol A; Bednarczuk T; Kolosza Z; Tukiendorf A; Szpak-Ulczok S; Stanjek-Cichoracka A; Polanska J; Jarzab B
PLoS One; 2013; 8(3):e59349. PubMed ID: 23544060
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor alpha (TNF-alpha) polymorphisms in Chinese patients with Graves' disease.
Gu LQ; Zhu W; Pan CM; Zhao L; Zhang MJ; Liu JM; Song HD; Ning G; Zhao YJ
Clin Biochem; 2010 Feb; 43(3):223-7. PubMed ID: 19732761
[TBL] [Abstract][Full Text] [Related]
18. Linkage disequilibrium between TNF-α-308 G/A promoter and histocompatibility leukocyte antigen alleles in Han-nationality lung transplant recipients from Eastern China.
Huijun M; Ji Z; Ping X; Jingyu C; Bin Z
Exp Clin Transplant; 2013 Jun; 11(3):264-9. PubMed ID: 23176610
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 gene polymorphisms in patients with Graves' disease.
Bednarczuk T; Placha G; Jazdzewski K; Kurylowicz A; Kloza M; Makowska U; Hiromatsu Y; Nauman J
Clin Endocrinol (Oxf); 2003 Oct; 59(4):519-25. PubMed ID: 14510917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
